The Pharmacovigilance Unit of Coimbra (UFC) is a Regional Unit of the National Pharmacovigilance System which is supported through a contract with the National Authority of Medicines and Health Products (INFARMED, IP).
The Data Centre is a structure to support Investigator Initiated Research providing Data Management and Electronic Data Capture Solutions.
The Quality Management System (QMS) has the necessary resources to provide the services and meet the needs and expectations of its Clients and interested parties.
The Translational Research and Technology Transfer Unit is responsible to provide all the support to facilitate and promote the transfer of R&D activities and pre-clinical studies to the development of clinical studies and to enhance the adoptions of best practices in the community.
Prof. Cunha-Vaz talks about ophthalmology, AIBILI and Coimbra. Please read complete interview here.
AIBILI is proud to announce that our researcher Prof. Rufino Silva was awarded with the 2020 European Society of Retina Specialists (EURETINA) Clinical Research Award with the project “Metabolomics: A Tool for Investig
Nesta edição do boletim “FARMACOVIGILÂNCIA: Atualizações de segurança de medicamentos” informa-se acerca das novas medidas para evitar erros na administração de medicamentos contendo leuprorrelina e relembra-
Don't miss the opportunity to participate in the Workshop dedicated to Good Clinical Practices, organized by CUF Academic and Research Medical Center and AIBILI-Association for Innovation and Biomedical Research on Light
The AIBILI General Assembly met on June 16, 2020, and approved new governing bodies composition as below: General Assembly: Coimbra University - Luís Simões da Silva SUCH –
Nesta edição do boletim “FARMACOVIGILÂNCIA: Atualizações de segurança de medicamentos” destaca-se a evidência acerca da utilização de hidroxicloroquina no tratamento de doentes com COVID-19 e potencial assoc
Alerta de Segurança - Hidroxicloroquina: risco de reações adversas cardíacas em doentes com COVID-19 A hidroxicloroquina está a ser estudada no tratamento de doentes com COVID-19. Os resultados de estudos prelimina
We would like to inform you that due to the containment measures for the Coronavirus outbreak the normal activity of AIBILI could be affected. However a contingence plan is already in place allowing our collaborators to
O Livro Branco das Doenças Raras é o resultado de um esforço conjunto do Grupo de Trabalho das Doenças Raras da P-BIO e do Centro de Avaliação de Tecnologias de Saúde e Investigação do Medicamento da AIBILI cont
A AIBILI e a ESEnfC assinaram um acordo de parceria para o desenvolvimento de atividades de investigação clínica destas duas instituições da cidade de Coimbra. Encontram, + info
A CUF e a AIBILI estabeleceram uma parceria para o desenvolvimento de investigação clínica que irá permitir reforçar as competências de ambas as instituições e unir esforços para a concretização de projetos re
Nesta edição do boletim “FARMACOVIGILÂNCIA: Atualizações de segurança de medicamentos” informa-se acerca de várias questões relacionadas com a segurança de domperidona, nivolumab, carfilzomib, mebutato de in
AIBILI aims to reinforce its Health Technology Assessment and Drug Research Centre with a Researcher on Economic Evaluation of Health Technologies Applications here: https
The journal Ophthalmic Research has just published a commemorative issue in Honour of Professor José Cunha-Vaz and his achievements in Diabetic Retinopathy, and ground-breaking contribution to basic sci
The 1st Meeting of the Drug Safety and Effectiveness Network (DruSER.net) took place on December 13, 2019. It was an important event to present this network coordinated by CHAD-AIBILI and t
The Centre for Health Technology Assessment and Drug Research of AIBILI will organize on December 13, 2019 the first meeting of the Drug Safety and Effectiveness Research Network. Please check here the p
AIBILI wishes you a joyous Holiday Season and a prosperous New Year!
AIBILI was present at the EATRIS - European Infrastructure for translational Medicine, National Hub Kick off Meeting, at INFARMED, Lisbon. In this meeting, which counted with the presence of EATRIS international repre
Nesta edição do boletim “FARMACOVIGILÂNCIA: Atualizações de segurança de medicamentos” informa-se acerca de várias questões relacionadas com a segurança de metotrexato, fingolimod, montelucaste, terapia horm
We are pleased to announce our latest publication on RetmarkerAMD® validation, published in the Eye newspaper, a Springer Nature group and official publication of the UK College of Ophthalmologists. By conducting a c
AIBILI was represented by Diogo Mendes at the 19th Annual Meeting of the ISoP International Society of Pharmacovigilance, in Bogotá (Colombia, October 26 to 29).
AIBILI organized in the EVICR.net annual Members Meeting, on October 24 and 25, at Infarmed (Lisbon) that was attended by about 100 participants who had the opportunity to update on the activities in the different subspe
Members of CHAD team were present on the 8th Pharmacovigilance Seminar of Spanish Pharmacovigilance System for Medicinal Products for Human Use, took place in Tordesillas, Spain, on October 23-25. This was the
Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 6, Nº 2 - 2º Trimestre . Consulte: + info
AIBILI was present at TECH@PORTUGAL, on the 4th of July at Alfândega do Porto, an event that presented the best Portuguese innovation and technology. We would like to thank to our partner Retmarker to the support, an
Decorreu no dia 06/06/2019 o Demonstrador Tecnológico AIBILI. Este evento foi organizado em parceria pela Agência Nacional de Inovação (ANI) e a AIBILI, e contará com a presença do Sr. Prof. Eduardo Maldonado, Pres
[video width="1280" height="720" mp4="https://www.aibili.pt/wp-content/uploads/2019/06/Demonstradortecnologico.mp4"][/video] Partilhamos agora o testemunho do Prof. Cunha-Vaz sobre o nosso Demonstrador Tecnológico, r
AIBILI participated in the BIOMEET 2019 to celebrate 20 years of P-BIO. The event took place in Carcavelos on 07/05/2019. Please see here the programme<
Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 6, Nº 1 Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Pharmacovigilance Unit of Coimbra (UFC) delivering to
A AIBILI recebeu a visita de estudantes de Eng.ª Física e Eng.ª Biomédica da Universidade e Coimbra no dia 19 de Março. Foi efetuada uma apresentação institucional da AIBILI pela Doutora Maria Madeira da UTT, uma
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Pharmacovigilance Unit of Coimbra (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medi
AIBILI has co-organized the Onco Pharmacovigilance Conference that was held in Coimbra on 24-25 of January 2019. ONCO Pharmacovigilance Conference is an event to join health professionals in order to address the safety a
Edifício Prof. Doutor José Cunha-Vaz
Azinhaga Sta. Comba, Celas
Portugal Geographical coordinates:
40º 13' 06,24" N
8º 24' 54,83" O
Telephone: +351 239 480100
Fax: +351 239 480117